250 related articles for article (PubMed ID: 17095076)
21. [Practice patterns of general practitioners in the Loire-Atlantique region and their patients' knowledge of prostate cancer screening].
Burin B; Bouchot O; Rigaud J
Prog Urol; 2006 Nov; 16(5):559-63. PubMed ID: 17175951
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer screening and informed decision-making: provider and patient perspectives.
Bowen DJ; Hannon PA; Harris JR; Martin DP
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):155-61. PubMed ID: 21243007
[TBL] [Abstract][Full Text] [Related]
23. Has there been a change in practice of screening for prostate cancer with prostate-specific antigen in Ontario?
Bunting PS
Clin Biochem; 2004 Oct; 37(10):898-903. PubMed ID: 15369721
[TBL] [Abstract][Full Text] [Related]
24. [Dissemination of evidence-based information about PSA test and prostatic cancer to physicians].
Norderhaug IN; Wisløff T; Fosså S; Sandberg S; Malde K; Forland F; Førde OH
Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2893-5. PubMed ID: 15550959
[TBL] [Abstract][Full Text] [Related]
25. Underutilization of digital rectal examination when screening for prostate cancer.
Murthy GD; Byron DP; Pasquale D
Arch Intern Med; 2004 Feb; 164(3):313-6. PubMed ID: 14769627
[TBL] [Abstract][Full Text] [Related]
26. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
27. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.
Haggerty J; Tudiver F; Brown JB; Herbert C; Ciampi A; Guibert R
Can Fam Physician; 2005 Dec; 51(12):1658-9. PubMed ID: 16926946
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
[TBL] [Abstract][Full Text] [Related]
29. Screening for prostate cancer: a survey of New Zealand general practitioners.
Durham J; Low M; McLeod D
N Z Med J; 2003 Jun; 116(1176):U476. PubMed ID: 12835804
[TBL] [Abstract][Full Text] [Related]
30. Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
Chun FK; Suardi N; Perrotte P; Lebeau T; Guay JP; Benayoun S; Ramirez A; Bénard F; McCormack M; Valiquette L; Karakiewicz P
Can J Urol; 2007 Dec; 14(6):3727-33. PubMed ID: 18163923
[TBL] [Abstract][Full Text] [Related]
31. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?
Tudiver F; Guibert R; Haggerty J; Ciampi A; Medved W; Brown JB; Herbert C; Katz A; Ritvo P; Grant B; Goel V; Smith P; O'Beirne M; Williams JI; Moliner P
J Fam Pract; 2002 Sep; 51(9):760. PubMed ID: 12366894
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
34. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
Kuo NW; Lin HC; Lee HC
J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
[TBL] [Abstract][Full Text] [Related]
35. Prostate-specific antigen testing: uncovering primary care influences.
Gormley GJ; Catney D; McCall JR; Reilly PM; Gavin AT
BJU Int; 2006 Nov; 98(5):996-1000. PubMed ID: 17034601
[TBL] [Abstract][Full Text] [Related]
36. PSA screening: determinants of primary-care physician practice patterns.
Tasian GE; Cooperberg MR; Potter MB; Cowan JE; Greene KL; Carroll PR; Chan JM
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):189-94. PubMed ID: 22343837
[TBL] [Abstract][Full Text] [Related]
37. PSA testing in general practice.
Little B; Ho KJ; Gormley G; Young M
Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
[TBL] [Abstract][Full Text] [Related]
38. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Crawford ED; Kramer BS; Andriole GL; Gelmann EP; Grubb R; Greenlee R; Gohagan JK
BJU Int; 2007 Apr; 99(4):775-9. PubMed ID: 17223921
[TBL] [Abstract][Full Text] [Related]
39. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud].
Praz V; Jichlinski P; Aymon D; Leisinger HJ
Rev Med Suisse; 2005 Dec; 1(44):2840-2. PubMed ID: 16382715
[TBL] [Abstract][Full Text] [Related]
40. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
